• 'Aquaporin-omics': mechanisms of aquaporin-2 loss in polyuric disorders
• A Case of Hypernatremia With Dementia
• A case of ifosfamide-induced acute kidney injury, Fanconi syndrome, and nephrogenic diabetes insipidus
• A case of nephrogenic diabetes insipidus likely caused by anti-neutrophil cytoplastic antibody-associated vasculitis
• A case of pregnancy with severe polyhydramnios related to long-term use of lithium
• A Novel AQP2 Sequence Variant Causing Aquaporin-2 Retention in the Cytoplasm and Autosomal Dominant Nephrogenic Diabetes Insipidus
• A novel association of osmotic demyelination in Sjögren's syndrome prompts revisiting role of aquaporins in CNS demyelinating diseases: A literature review
• A novel AVPR2 gene mutation in a Chinese pedigree with nephrogenic diabetes insipidus
• A Rare Case of Congenital Nephrogenic Diabetes Insipidus Associated with Aquaporin 2 Gene Mutation and Subsequent Acute Lymphoblastic Leukemia: Impact of Steroids on Kidney Function
• An exceptional cause of polyuria-polydipsia syndrome in a 10-year-old boy
• Approach to the patient with suspected hypotonic polyuria
• Aquaporins in Diabetes Insipidus
• Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency
• Arginine Vasopressin Disorder (Diabetes Insipidus)
• Autophagy and regulation of aquaporins in the kidneys
• beta3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Diabetes Insipidus
• Bioinformatics-guided Disproportionality Analysis of Sevoflurane-Induced Nephrogenic Diabetes Insipidus using the FDA Adverse Event Reporting System (FAERS) Database
• Bioinformatics-guided disproportionality analysis of sevoflurane-induced nephrogenic diabetes insipidus using the FDA Adverse Event Reporting System database
• Cannabinoid receptor type 1 activation causes a water diuresis by inducing an acute central diabetes insipidus in mice
• Central diabetes insipidus and burn trauma
• Central diabetes insipidus and partial anterior pituitary dysfunction in acute myeloid leukemia
• Central Diabetes Insipidus in the Background of Lithium Use: Consider Central Causes Despite Nephrogenic as the Most Common
• Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus
• Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus
• Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus
• Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus
• Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus
• Chronic Lithium Intoxication: A Challenging Diagnosis
• Clinical and laboratory characteristics of arginine vasopressin resistance, caused by a new homozygous mutation p.R113C in AQP2
• Clinical management of unremitting nephrogenic diabetes insipidus
• Clinical manifestations and renal pathology of ethylene glycol
• Comprehensive analysis of clinical and laboratory features of 440 published cases of Sjögren's syndrome and renal tubular acidosis
• Congenital nephrogenic diabetes insipidus arginine vasopressin receptor 2 gene mutation at new site: A case report
• Congenital nephrogenic diabetes insipidus treated with acetazolamide
• Copeptin as a surrogate marker for arginine vasopressin: analytical insights, current utility, and emerging applications
• Copeptin levels in hospitalized infants and children with suspected vasopressin-dependent disorders: a case series
• Diabetes insipidus: Vasopressin deficiency
• Diabetes insipidus: vasopressin deficiency…
• Diabetes insipidus: Vasopressin deficiencya
• Diabetes insipidus: Vasopressin deficiency…
• Diagnostic Accuracy of Copeptin in the Differential Diagnosis of Patients With Diabetes Insipidus: A Systematic Review and Meta-analysis
• Diagnostic Pitfalls of a Newborn with Congenital Nephrogenic Diabetes Insipidus
• Early onset of nephrogenic diabetes insipidus due to fabry disease in a child with <em>GLA</em> N215S mutation: Case report and literature review
• Early onset of nephrogenic diabetes insipidus due to fabry disease in a child with GLA N215S mutation: Case report and literature review
• Exploring the diversity of AVPR2 in Primates and its evolutionary implications
• Family form of nephrogenic X-linked diabetes indiabetes
• Fanconi syndrome, diabetes insipidus, and acute kidney injury due to tenofovir disoproxil fumarate: A case report
• First report on female monozygotic twins discordant for congenital nephrogenic diabetes insipidus
• Genetic analysis of nephrogenic diabetes insipidus patients: A study on the Iranian population
• Genetic basis of nephrogenic diabetes insipidus
• Genetic deletion of the nuclear factor of activated T cells 5 in collecting duct principal cells causes nephrogenic diabetes insipidus
• How to improve ChatGPT performance for nephrologists: a technique guide
• Hydrochlorothiazide-Induced Exfoliative Rash and Sepsis
• Iatrogenic Cushing syndrome in a child due to erroneous compounding of omeprazole containing glucocorticoid: A case report and literature review
• Iatrogenic endocrine complications of lithium therapy
• Idiopathic partial central diabetes insipidus
• Ifosfamide-induced nephrotoxicity in oncological patients
• Lithium poisoning and renal replacement therapy: pathophysiology and current clinical recommendations
• Lithium-Associated Nephrogenic Diabetes Insipidus or Catatonic Stereotypical Drinking?: A Case Report and Literature Review
• Lithium-Induced Arginine Vasopressin Resistance (AVP-R): A Case of Chronic Exposure to Lithium
• Lithium-induced nephrogenic diabetes insipidus during acute intoxication: a case report
• Lithium-induced Nephrogenic Diabetes Insipidus with Efficacy of Desmopressin in Combination with Thiazide Diuretics and Non-steroidal Anti-inflammatory Drugs: A Case Report with a Review of the Literature
• Low exposition to lithium prevents nephrogenic diabetes insipidus but not microcystic dilations of the collecting ducts in long-term rat model
• Loxapine in the Treatment of Manic and Psychotic Symptoms in an Individual Intolerant to Multiple Mood-Stabilizing and Antipsychotic Medications
• Metabolic reprogramming of renal epithelial cells contributes to lithium-induced nephrogenic diabetes insipidus
• Nephrogenic diabetes insipidus after inhalation sedation with sevoflurane in a patient with COVID-19-associated acute respiratory distress syndrome
• Nephrogenic Diabetes Insipidus and Distal Renal Tubular Acidosis in a Patient with Systemic Lupus Erythematosus and Secondary Antiphospholipid Syndrome
• Nephrogenic Diabetes Insipidus in a 10-mo-old Infant: Complication of Nephropathic Cystinosis
• Nephrogenic diabetes insipidus in a geriatric patient affected by SARS-CoV-2: complexity of a diagnosis, complexity of a virus
• Neuroleptic Malignant Syndrome in a Patient with Lithium-induced Nephrogenic Diabetes Insipidus: A Case Report
• New developments and concepts in the diagnosis and management of diabetes insipidus (AVP-deficiency and resistance)
• Pathophysiology of Drug-Induced Hyponatremia
• Pattern of hereditary renal tubular disorders in Egyptian children
• Perioperative Infusion Management for Adhesive Bowel Obstruction with Congenital Nephrogenic Diabetes Insipidus: A Case Report
• Primary Polydipsia
• Primary Polydipsia
• Profound hyponatremia and dehydration: A case of cisplatin induced renal salt wasting syndrome
• Retracted: A Novel Missense Mutation of Arginine Vasopressin Receptor 2 in a Chinese Family with Congenital Nephrogenic Diabetes Insipidus: X-Chromosome Inactivation in Female CNDI Patients with Heterozygote 814A>G Mutation
• Single hormone or synthetic agonist induces G_s/G_i coupling selectivity of EP receptors via distinct binding modes and propagating paths
• Structural and functional analysis of aquaporin-2 mutants involved in nephrogenic diabetes insipidus
• Successful Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus with Celecoxib: A Promising Therapeutic Option
• Tamoxifen Affects Aquaporin-3 Expression and Subcellular Localization in Rat and Human Renal Collecting Ducts
• Targeted long-read sequencing identified a causal structural variant in X-linked nephrogenic diabetes insipidus
• The beta3-AR agonist BRL37344 ameliorates the main symptoms of X-linked nephrogenic diabetes insipidus in the mouse model of the disease
• The diagnostic performance of copeptin in clinical practice: A prospective study
• The First Case of Congenital Nephrogenic Diabetes Insipidus Caused by <em>AVPR2</em> Disruption Because of 4q25 Insertional Translocation
• The First Case of Congenital Nephrogenic Diabetes Insipidus Caused by AVPR2 Disruption Because of 4q25 Insertional Translocation
• The laboratory investigation of diabetes insipidus: A review
• Therapeutic potentials of nonpeptidic V2R agonists for partial cNDI-causing V2R mutants
• Thirst, Hunger, and Nephrogenic Diabetes Insipidus
• Three Pediatric Patients with Congenital Nephrogenic Diabetes Insipidus due to <em>AVPR2</em> Nonsense Mutations and Different Clinical Manifestations: A Case Report
• Three Pediatric Patients with Congenital Nephrogenic Diabetes Insipidus due to AVPR2 Nonsense Mutations and Different Clinical Manifestations: A Case Report
• Transient distal renal tubular acidosis with nephrogenic diabetes insipidus after general anaesthesia in a dog
• Tubular Diseases and Stones Seen From Pediatric and Adult Nephrology Perspectives
• Urine concentration defects including nephrogenic diabetes insipidus in patients with Sjogren's Syndrome and renal tubular acidosis
• Urine concentration impairment in sickle cell anemia: genuine nephrogenic diabetes insipidus or osmotic diuresis?
• Use of copeptin in interpretation of the water deprivation test
• V2 vasopressin receptor mutations: future personalized therapy based on individual molecular biology
• When Thirst Ceases to Exist: A Case Report and Literature Review of Adipsic Diabetes Insipidus Following Coil Embolization of a Ruptured Anterior Communicating Artery Aneurysm
• β3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Diabetes Insipidus